Trademarkia Logo

Australia

AU$
Trademark Search
ONCXERNA

View On IPO.GOV.AU

ONCXERNA
Protected: Registered/protected

Last updated on 5 May 2021

Owner Info

ONCXERNA THERAPEUTICS, INC.

300 Fifth Avenue, Suite 6040

Waltham MA 02451, UNITED STATES OF AMERICA

Serial Number

2142278 filed on 3 Nov 2020

Correspondent

Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.

1100 New York Avenue, NW,

Washington DC 20005,

UNITED STATES OF AMERICA

ONCXERNA

Classification Information

Class [001]
Chemical, biological, biochemical and biotechnological products and preparations for industrial and scientific purposes, namely, small molecules, biol Read More

Class [005]
Pharmaceutical preparations, namely, proteins for the treatment and diagnosis of cancer, viral infections and infectious diseases; diagnostic kits con Read More

Class [042]
Biological and biotechnology research; research and development in the pharmaceutical and biotechnology fields; scientific research and development wi Read More

Mark Details

Serial Number

2142278

Registered On

3 Nov 2020

Renewal On

3 Nov 2030

Mark Type

FIGURATIVE

Priority Claim (Convention Details)

Date

25 Sept 2020

Mark Type

US

Legal History

Show more

Status DateAction Taken
5th May 2021International Registration in Australia Protected correspondence sent
4th May 2021IP Right Registration Published
4th May 2021Status change to Registered/Protected
26th Feb 2021Application Accepted correspondence sent
26th Feb 2021IP Right has been Examined
26th Feb 2021IP Right Acceptance Published
24th Dec 2020Status change to Accepted
11th Dec 2020Awaiting examination
11th Dec 2020Examination expedited
11th Dec 2020Word and image indexing completed